PeptideDB

GSK8573 1693766-04-9

GSK8573 1693766-04-9

CAS No.: 1693766-04-9

GSK8573 is an inactive control compound for GSK2801, an acetyl-lysine competitive inhibitor of the BAZ2A and BAZ2B bromo
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

GSK8573 is an inactive control compound for GSK2801, an acetyl-lysine competitive inhibitor of the BAZ2A and BAZ2B bromodomains. GSK8573 has binding activity to BRD9 with Kd of 1.04 μM and is inactive against BAZ2A/B and other bromodomain families. GSK8573 can be used as a structurally related negative control (NC) compound in biological experiments.

Physicochemical Properties


Molecular Formula C20H21NO3
Molecular Weight 323.385645627975
Exact Mass 323.152
CAS # 1693766-04-9
Related CAS # 1693766-04-9 GSK8573
PubChem CID 121230107
Appearance Light yellow to yellow solid powder
Density 1.1±0.1 g/cm3
Index of Refraction 1.569
LogP 4.44
Hydrogen Bond Donor Count 0
Hydrogen Bond Acceptor Count 3
Rotatable Bond Count 6
Heavy Atom Count 24
Complexity 427
Defined Atom Stereocenter Count 0
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro GSK8573 (1.0 μM) is inert against BAZ2A/B and other bromodomain families, but has binding activity to BRD9 with a Kd value of 1.04 μM [1].
References

[1]. Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2B. J Med Chem. 2016 Feb 25;59(4):1410-24.


Solubility Data


Solubility (In Vitro) DMSO : ~25 mg/mL (~77.31 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (7.73 mM) (saturation unknown) in 10% DMSO + 40% PEG300 +5% Tween-80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 + to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 3.0922 mL 15.4612 mL 30.9224 mL
5 mM 0.6184 mL 3.0922 mL 6.1845 mL
10 mM 0.3092 mL 1.5461 mL 3.0922 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.